Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease

• Status: Withdrawn
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to test whether once-weekly prozac therapy leads to reduction in depression in patients requiring kidney dialysis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Creighton University
• Treatments: Fluoxetine

Criteria

Inclusion Criteria:

• Diagnosis of chronic renal failure and end stage renal disease

• Ongoing need for regular dialysis treatment

• Diagnosis of depression based on DSMIV

• Age tween 19-65 years

Exclusion Criteria:

• Inability to provide informed consent

• Medically or psychiatrically unstable, as defined by requiring inpatient treatment

• Pregnancy, nursing or refusal to use a reliable method of birth control in women

• Patients with known allergy to fluoxetine, or previous treatment failure of fluoxetine